Back
Maze Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
MAZE
Maze Therapeutics
Last Price:
$9.98
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MAZE is experiencing slight buying pressure.
Maze Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.61 | Buy |
20-day SMA: | 9.45 | Buy |
50-day SMA: | 9.86 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 9.53 | Buy |
20-day EMA: | 9.5 | Buy |
50-day EMA: | 6.66 | Buy |
200-day EMA: | 2.49 | Buy |
Maze Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 50.9 | Buy |
Chaikin Money Flow: | 44500 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.45 - 10.07) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Maze Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Maze Therapeutics Stock
Is Maze Therapeutics Stock a Buy?
-
Maze Therapeutics share price is 9.70 while MAZE 8-day simple moving average is 9.61, which is a Buy signal.
-
The stock price of MAZE is 9.70 while Maze Therapeutics 20-day SMA is 9.45, which makes it a Buy.
-
Maze Therapeutics 50-day simple moving average is 9.86 while MAZE share price is 9.70, making it a Sell technically.
-
MAZE stock price is 9.70 and Maze Therapeutics 200-day simple moving average is 0.00, creating a Buy signal.
MAZE Technical Analysis vs Fundamental Analysis
Sell
26
Maze Therapeutics (MAZE)
is a Sell
Is Maze Therapeutics a Buy or a Sell?
-
Maze Therapeutics stock is rated a SellThe current Maze Therapeutics [MAZE] share price is $9.70. The Score for MAZE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Maze Therapeutics Stock Info
Market Cap:
415.4M
Price in USD:
9.70
Share Volume:
88.4K
Maze Therapeutics 52-Week Range
52-Week High:
17.00
52-Week Low:
6.71
Sell
26
Maze Therapeutics (MAZE)
is a Sell
Maze Therapeutics Share Price Forecast
-
What is the Maze Therapeutics stock price today?The Maze Therapeutics stock price is 9.70 USD today.
-
Will MAZE stock go up or go down?Maze Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Maze Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Maze Therapeutics is overvalued.
Is Maze Therapeutics Stock a Buy?
-
Maze Therapeutics share price is 9.70 while MAZE 8-day exponential moving average is 9.53, which is a Buy signal.
-
The stock price of MAZE is 9.70 while Maze Therapeutics 20-day EMA is 9.50, which makes it a Buy.
-
Maze Therapeutics 50-day exponential moving average is 6.66 while MAZE share price is 9.70, making it a Buy technically.
-
MAZE stock price is 9.70 and Maze Therapeutics 200-day simple moving average is 2.49, creating a Buy signal.
Fundamental Analysis of Maze Therapeutics
Is Maze Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.13 per share, an increase this year of $15.17 per share, and an increase next year of $1.67 per share.
Technical Analysis of Maze Therapeutics
Should I short Maze Therapeutics stock?
-
MAZE Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Maze Therapeutics is a Sell
-
Maze Therapeutics Relative Strength Index (RSI) is 50.9, which suggest Maze Therapeutics is overbought
-
The Bollinger Bands (25) for Maze Therapeutics is (8.45 - 10.07), which suggest Maze Therapeutics is a Buy
-
The Bollinger Bands (100) for Maze Therapeutics is ( - ), which suggest Maze Therapeutics is a Buy
* Maze Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.